Biofoundries are automated laboratory platforms that execute design-build-test-learn (DBTL) cycles at scale, generating vast experimental datasets with the potential to accelerate biological discovery and grow the bioeconomy. Independent development across institutions has produced incompatible data formats and no agreed schema linking experimental metadata across cycles or between facilities, preventing aggregation for cross-institutional validation, machine learning, and reproducibility. Neither the international consortium nor the formal standards body with the mandate to act has done so, leaving an organizational gap that no technical solution has yet resolved. Closing the gap will necessitate three sequential steps: a community-driven working group to establish minimum data standards and schema, a funded international pilot cohort to test and refine them, and downstream formalization through established standards bodies. Community consensus must run ahead of, not concurrently with, formal standardization. Both the Bermuda Principles and the Protein Data Bank demonstrate that global scientific communities can establish binding data norms without a mandate, through collective agreement or through incentive structures that make compliance desirable.
No takes yet. Share an insight, caveat, or question.
Jonathan Judd (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: